Abstract
The in vitro activity of azithromycin against human pathogenic strains ofBrucella melitensis was tested at three centres and compared to that of tetracycline, the standard antibiotic currently used for the treatment of human brucellosis. MIC determination was carried out. Tested concentration ranges for both azithromycin and tetracycline were between 0.03 and 16 µg/ml.Brucella melitensis biotype 1, strain M16 was employed as a control microorganism. A total of 358Brucella melitensis strains from human blood cultures were tested. MIC90 (µg/ml) values ranged from 0.5 to 1.00 for azithromycin and were 0.25 for tetracycline. It was concluded that there was little difference in the sensitivity of pathogenicBrucella melitensis to azithromycin and tetracycline isolated from three different regions in Spain. These results encourage further investigations on the possible therapeutic role of azithromycin in brucellosis.
Similar content being viewed by others
References
Landínez R, Abad R, Rodriguez Torres A: Estudio sobre el tratamiento de la brucelosis. Infectologika 1984, 5: 7–14.
Ariza J, Gudiol F, Pallares R, Rufi G, Fernandez-Viladrich P: Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrobial Agents and Chemotherapy 1985, 28: 548–551.
Acocella G, Bertrand A, Beytout J., Duriande JB, Garcia Rodriguez JA, Kosmidis J, Micoud M, Rey M, Rodriguez Zapata M, Roux J, Stahl JP: Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. Journal of Antimicrobial Chemotherapy 1989, 23: 433–439.
Anonymous: Azithromycin. Drugs of the Future 1988, 13: 9–12.
Foulds G, Shepard RM, Johnson RB: The pharmacokinetics of azithromycin in human serum and tissues. Journal of Antimicrobial Chemotherapy 1990, 25, Supplement A: 73–82.
Gladue RP, Bright GM, Isaacson RE, Newborg MF: In vitro and in vivo uptake of azithromycin by phagocytic cells: possible mechanisms of delivery and release at sites of infection. Antimicrobial Agents and Chemotherapy 1989, 33: 277–282.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Landínez, R., Liñares, J., Loza, E. et al. In vitro activity of azithromycin and tetracycline against 358 clinical isolates ofBrucella melitensis . Eur. J. Clin. Microbiol. Infect. Dis. 11, 265–267 (1992). https://doi.org/10.1007/BF02098096
Issue Date:
DOI: https://doi.org/10.1007/BF02098096